- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Dasatinib Placebo
Total 55034 results
-
AHS Cancer Control AlbertaTom Baker Cancer CentreRecruitingGlioblastoma | Recurrent Glioblastoma | Recurrent DiseaseCanada
-
Versailles HospitalUniversity Hospital, Bordeaux; Maisonneuve-Rosemont HospitalCompletedChronic Myelogenous Leukemia, BCR/ABL PositiveFrance, Canada
-
Boehringer IngelheimTerminatedHead and Neck NeoplasmsUnited States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Czechia, Denmark, Egypt, Finland, France, Germany, Greece, Hungary, India, Israel, Italy, Japan, Mexico, Netherlands, Portugal, Russian Federation, Spain, Sweden, Switzerlan... and more
-
Sun Yat-sen UniversityNot yet recruitingNSCLC | Non-small Cell Lung CancerChina
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Korea, Republic of, Spain
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited Kingdom, United States, Peru, Israel, Poland, Russian Federation, Korea, Republic of, Thailand, Pakistan, Hungary, India, Canada, France, Mexico, Malaysia, Singapore
-
Nanfang Hospital of Southern Medical UniversityRecruitingLeukemia | Leukemia, B-cell | Leukemia, Acute | Leukemia, LymphoblasticChina
-
Mayo ClinicEnrolling by invitation
-
Radiation Therapy Oncology GroupGlaxoSmithKline; NovartisCompletedNon-HPV Locally Advanced Head and Neck CancerUnited States, Canada
-
GlaxoSmithKlineCompletedNeoplasms, BreastJapan
-
Peking Union Medical College HospitalJiangsu HengRui Medicine Co., Ltd.RecruitingGestational Trophoblastic NeoplasiaChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Astex Pharmaceuticals, Inc.RecruitingChronic Phase Chronic Myelogenous Leukemia | Philadelphia Chromosome Positive | BCR-ABL1 Positive Chronic Myelogenous Leukemia | BCR-ABL1 PositiveUnited States
-
GlaxoSmithKlineCompleted
-
University of Kansas Medical CenterTerminatedMetastatic Breast CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterGlaxoSmithKlineCompletedProstate CancerUnited States
-
Arbeitsgemeinschaft medikamentoese TumortherapieGlaxoSmithKlineTerminatedMetastatic Breast CancerAustria
-
Duke UniversityBristol-Myers SquibbTerminatedPancreatic Adenocarcinoma | Refractory Solid TumorsUnited States
-
AA SecordCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
Sun Yat-sen UniversityJiangsu Hengrui Pharmaceutical Co., Ltd.Not yet recruitingMetastatic Biliary Tract Cancer | Locally Advanced Biliary Tract CancerChina
-
First Affiliated Hospital Xi'an Jiaotong UniversityRecruitingPrecursor Cell Lymphoblastic Leukemia-Lymphoma | ALL, Adult | Philadelphia-Positive Acute Lymphoblastic LeukemiaChina
-
Shanghai Chest HospitalUnknownRecurrence | Metastasis | Esophageal Squamous Cell Carcinoma | ApatinibChina
-
Boehringer IngelheimApproved for marketing
-
University of Alabama at BirminghamGlaxoSmithKline; AbbVie; Breast Cancer Research Foundation of AlabamaActive, not recruitingMetastatic Triple Negative Breast CancerUnited States
-
Shenzhen Second People's HospitalRecruitingChronic Myeloid Leukemia | Dasatinib | BCR-ABLChina
-
Bristol-Myers SquibbCompletedChronic Myeloid Leukemia | Philadelphia-Positive Myeloid LeukemiaBelgium, Netherlands, Spain, United States, Italy, Canada, France, Germany, Peru, Singapore, United Kingdom, Australia, Sweden, Finland, Israel, Ireland, Denmark, Korea, Republic of, Norway, Austria, South Africa, Switzerland
-
Brown UniversityRhode Island Hospital; Memorial Hospital of Rhode IslandTerminatedA Study of Dasatinib With Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer (NSCLC)Non-Small Cell Lung CancerUnited States
-
GlaxoSmithKlineCompleted
-
Jian FangPeking University First Hospital; Peking University Third Hospital; The Second...Unknown
-
Jiangsu HengRui Medicine Co., Ltd.Fudan UniversityCompleted
-
Elevar TherapeuticsCompletedGastric Cancer | Gastric AdenocarcinomaUnited States, United Kingdom, Korea, Republic of, France, Taiwan, Japan, Russian Federation, Germany, Italy, Poland, Romania, Ukraine
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungUnited States, Belgium, Canada, China, France, Germany, Hong Kong, Italy, Korea, Republic of, Netherlands, Singapore, Spain, Taiwan, Thailand, United Kingdom
-
Stanford UniversityKite PharmaRecruitingLymphoblastic LeukemiaUnited States
-
Bristol-Myers SquibbCompletedMultiple Indications CancerFrance, Poland
-
Massachusetts General HospitalBristol-Myers Squibb; Dana-Farber Cancer Institute; Brigham and Women's HospitalCompleted
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingChronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveUnited States
-
Baylor Breast Care CenterGlaxoSmithKlineCompleted
-
National Cancer Institute (NCI)NCIC Clinical Trials GroupCompletedBrain and Central Nervous System TumorsCanada
-
GlaxoSmithKlineTerminatedLung Cancer, Non-Small CellUnited States, Canada
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Spain, Israel, Canada, Belgium, United Kingdom, France, Tunisia
-
Hung-Hsueh ChouBristol-Myers Squibb; GlaxoSmithKlineUnknown
-
GlaxoSmithKlineCompletedAdenocarcinomaNetherlands, United States, Peru
-
Consorzio OncotechUnknown
-
Novartis PharmaceuticalsCompletedNeoplasms, BreastUnited States
-
Fujian Medical UniversityRecruitingAdvanced Hepatocellular CarcinomaChina
-
Qingdao Central HospitalRecruiting
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Creighton UniversityNovartisUnknown
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungGreece
-
Boehringer IngelheimCompletedNeuroectodermal Tumors | RhabdomyosarcomaUnited States, Spain, Canada, Germany, Italy, United Kingdom, Australia, Austria, Denmark, Faroe Islands, France, Netherlands